Shared Decision-Making and Quality of Life in High-Risk Biochemical Recurrence Prostate Cancer

In this segment, Dr. Graham and Dr. Sokolova focus on shared decision-making in the management of high-risk biochemical recurrence prostate cancer. The discussion centers on how clinicians communicate the trade-offs between disease control, treatment burden, and quality of life when counseling patients about therapeutic options. Dr. Sokolova emphasizes the importance of incorporating patient preferences, values, and tolerability concerns into treatment recommendations, particularly in settings where overall survival benefit may be limited. Both experts highlight strategies for setting realistic expectations and engaging patients in informed discussions about potential benefits and risks. The conversation underscores that patient-centered care requires flexibility and ongoing reassessment as goals and circumstances evolve. Overall, this segment illustrates how thoughtful communication and individualized decision-making play a central role in managing high-risk BCR prostate cancer.